All lobbying filings
TIBER CREEK GROUP
Lobbying for JAZZ PHARMACEUTICALS · ​Biopharmaceutical company.
Filing
3rd Quarter - Report
Lobbying activity
3
Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxicating hemp.
Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services.
Issues related to House Ag/FDA Appropriations pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products; Issues related to the Ag/FDA amendment - technical correction to the 2026 Ag/FDA appropriations bill related to hemp; Issues related to intoxicating hemp products.